Research is being conducted on the potential benefits of GLP-1s, also known as incretins, in managing conditions such as hypertension and obesity. The role of GLP-1s in various therapeutic applications, including diabetes care and cardiovascular risk reduction, is being explored. Studies and discussions are underway to understand the mechanisms of action and potential uses of GLP-1s and related receptor agonists.